Clinical Trial Update: Study of Outcomes of Radiofrequency Ablation of Lung Tumors

View source ↗

Summary

This clinical trial update notes that the study on outcomes of radiofrequency ablation for lung tumors has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pulmonary Metastases

Snippet

Sponsor: University of Pittsburgh | Conditions: NSCLC, Pulmonary Metastases | Status: SUSPENDED